Real-time enrollment status for this iga nephropathy clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:50 AM UTC
| NCT Number | NCT06935357 |
| Recruiting Status | Recruiting |
| Condition | IgA Nephropathy |
| Phase | PHASE3 |
| Target Enrollment | 454 participants |
| Active Locations | 28 sites in the US |
| Sponsor | Biogen |
| Last Updated on CT.gov | July 15, 2026 (2 days ago) |
As of July 17, 2026: Clinical trial NCT06935357 is currently recruiting participants. This phase3 study for iga nephropathy is actively seeking new participants at 28 locations across the United States. The study is sponsored by Biogen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06935357 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06935357 was last updated 2 days ago (July 15, 2026). HelloStudys verifies this status automatically.